Schizophrenia before the age of 18 years is usually divided into two categories. Early-onset schizophrenia (EOS) presents between the ages of 13 and 17 years, whereas very-early-onset schizophrenia (VEOS) presents at or before the age of 12 years. Previous studies have found that neurodevelopmental difficulties in social, motor, and linguistic domains are commonly observed in VEOS/EOS patients. Recent research has also shown a high prevalence of neurodevelopmental disorders (e.g., intellectual disability, communication disorders, autism spectrum disorder, neurodevelopmental motor disorders) in VEOS/EOS patients, indicating genetic overlap between these conditions. These findings lend support to the neurodevelopmental continuum model, which ...
Schizophrenia is a chronic disorder associated with deficits in cognition, affect, and social functi...
BackgroundEarly-Onset Schizophrenia (EOS) is rare but severe mental health disorder in children and ...
Despite the growing interest in a dimensional approach to the assessment of symptoms and clinically ...
Although schizophrenia has been diagnosed in children, this group of disorders has received too litt...
Although schizophrenia has been diagnosed in children, this group of disorders has received too litt...
Very early onset and early onset schizophrenia – which manifest themselves before the age of 13 (the...
Schizophrenia and bipolar disorders share not only clinical features but also some risk factors such...
The neurodevelopmental hypothesis of schizophrenia provided a valuable framework that allowed a cond...
Background: The aim of this study was to assess the association between the clinical and neurobiolog...
Cognitive deficits are a core feature of schizophrenia and appear with increased severity in early-o...
Large individual variation in the clinical presentation of schizophrenia-spectrum disorders raises k...
Background Being in a period with extensive brain maturation, adolescents with early‐onset schizoph...
The issue of neurodegeneration in schizophrenia is contro-versial. Although most studies indicate th...
BACKGROUND: Schizophrenia has a neurodevelopmental component to its origin, and may share overlappi...
Background: Autism spectrum disorder (ASD) and childhood onset schizophrenia (COS) are pediatric neu...
Schizophrenia is a chronic disorder associated with deficits in cognition, affect, and social functi...
BackgroundEarly-Onset Schizophrenia (EOS) is rare but severe mental health disorder in children and ...
Despite the growing interest in a dimensional approach to the assessment of symptoms and clinically ...
Although schizophrenia has been diagnosed in children, this group of disorders has received too litt...
Although schizophrenia has been diagnosed in children, this group of disorders has received too litt...
Very early onset and early onset schizophrenia – which manifest themselves before the age of 13 (the...
Schizophrenia and bipolar disorders share not only clinical features but also some risk factors such...
The neurodevelopmental hypothesis of schizophrenia provided a valuable framework that allowed a cond...
Background: The aim of this study was to assess the association between the clinical and neurobiolog...
Cognitive deficits are a core feature of schizophrenia and appear with increased severity in early-o...
Large individual variation in the clinical presentation of schizophrenia-spectrum disorders raises k...
Background Being in a period with extensive brain maturation, adolescents with early‐onset schizoph...
The issue of neurodegeneration in schizophrenia is contro-versial. Although most studies indicate th...
BACKGROUND: Schizophrenia has a neurodevelopmental component to its origin, and may share overlappi...
Background: Autism spectrum disorder (ASD) and childhood onset schizophrenia (COS) are pediatric neu...
Schizophrenia is a chronic disorder associated with deficits in cognition, affect, and social functi...
BackgroundEarly-Onset Schizophrenia (EOS) is rare but severe mental health disorder in children and ...
Despite the growing interest in a dimensional approach to the assessment of symptoms and clinically ...